Wheelock, Vicki et al "PRE-CELL: Clinical and Novel Biomarker Measures of Disease Progression in a Lead-In-Observational Study for a Planned Phase 1 Trial of Genetically-Modified Mesenchymal Stem Cells Over-Expressing BDNF in Patients with Huntington’s Disease (S25.004)." Neurology 86.16 Supplement (2016): S25.004. Web. 14 Oct. 2019.